126 related articles for article (PubMed ID: 1927563)
1. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients.
Vitiello B; Shimon H; Behar D; Stoff D; Bridger WH; Friedman E
Acta Psychiatr Scand; 1991 Jul; 84(1):29-32. PubMed ID: 1927563
[TBL] [Abstract][Full Text] [Related]
2. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients.
Bastani B; Arora RC; Meltzer HY
Biol Psychiatry; 1991 Jul; 30(2):131-9. PubMed ID: 1655071
[TBL] [Abstract][Full Text] [Related]
3. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
Weizman A; Carmi M; Hermesh H; Shahar A; Apter A; Tyano S; Rehavi M
Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
[TBL] [Abstract][Full Text] [Related]
4. Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder.
Weizman A; Mandel A; Barber Y; Weitz R; Cohen A; Mester R; Rehavi M
Biol Psychiatry; 1992 Apr; 31(7):705-11. PubMed ID: 1318082
[TBL] [Abstract][Full Text] [Related]
5. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
[TBL] [Abstract][Full Text] [Related]
6. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
Kim SW; Dysken MW; Pandey GN; Davis JM
Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
[TBL] [Abstract][Full Text] [Related]
7. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
Cath DC; Spinhoven P; Landman AD; van Kempen GM
J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
[TBL] [Abstract][Full Text] [Related]
8. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.
Delorme R; Betancur C; Callebert J; Chabane N; Laplanche JL; Mouren-Simeoni MC; Launay JM; Leboyer M
Neuropsychopharmacology; 2005 Aug; 30(8):1539-47. PubMed ID: 15886722
[TBL] [Abstract][Full Text] [Related]
9. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
Black DW; Kelly M; Myers C; Noyes R
Biol Psychiatry; 1990 Feb; 27(3):319-27. PubMed ID: 2154266
[TBL] [Abstract][Full Text] [Related]
10. Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.
Marazziti D; Hollander E; Lensi P; Ravagli S; Cassano GB
Psychiatry Res; 1992 Apr; 42(1):41-51. PubMed ID: 1603880
[TBL] [Abstract][Full Text] [Related]
11. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder.
Pfohl B; Black D; Noyes R; Kelley M; Blum N
Biol Psychiatry; 1990 Jul; 28(1):41-6. PubMed ID: 2165423
[TBL] [Abstract][Full Text] [Related]
12. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
Nelson EC; Sheline YI; Bardgett ME; Jackson JL; Csernansky JG
Psychiatry Res; 1995 Sep; 58(2):117-25. PubMed ID: 8570763
[TBL] [Abstract][Full Text] [Related]
13. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
Marazziti D; Rossi A; Gemignani A; Giannaccini G; Pfanner C; Milanfranchi A; Presta S; Lucacchini A; Cassano GB
Neuropsychobiology; 1996; 34(4):184-7. PubMed ID: 9121618
[TBL] [Abstract][Full Text] [Related]
14. Personality features and platelet 3H-imipramine binding.
Castrogiovanni P; Maremmani I; Di Muro A; Rotondo A; Marazziti D
Neuropsychobiology; 1992; 25(1):11-3. PubMed ID: 1318512
[TBL] [Abstract][Full Text] [Related]
15. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects.
Halbreich U; Rojansky N; Zander KJ; Barkai A
J Psychiatr Res; 1991; 25(1-2):7-18. PubMed ID: 1851224
[TBL] [Abstract][Full Text] [Related]
16. Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".
Paul SM; Rehavi M; Skolnick P; Ballenger JC; Goodwin FK
Arch Gen Psychiatry; 1981 Dec; 38(12):1315-7. PubMed ID: 7316676
[TBL] [Abstract][Full Text] [Related]
17. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.
Sallee FR; Richman H; Beach K; Sethuraman G; Nesbitt L
J Am Acad Child Adolesc Psychiatry; 1996 Dec; 35(12):1647-56. PubMed ID: 8973072
[TBL] [Abstract][Full Text] [Related]
18. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
[TBL] [Abstract][Full Text] [Related]
19. Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding.
Poirier MF; Galzin AM; Pimoule C; Schoemaker H; Le Quan Bui KH; Meyer P; Gay C; Loo H; Langer SZ
Psychopharmacology (Berl); 1988; 94(4):521-6. PubMed ID: 3131797
[TBL] [Abstract][Full Text] [Related]
20. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
Zohar J; Insel TR
Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
